Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial
Galimberti V et al. Axillary dissection versus no
axillary dissection in patients with sentinel-node
micrometastases (IBCSG 23-01): a phase 3
randomised controlled trial. Lancet Oncol 2013;
14: 297–305. doi: 10.1016/S1470-
2045(13)70035-4